Market Tracker

04/17 6:05pm ET

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

53.91
Data as of Apr 17
 -0.75 / -1.37%
Today’s Change
21.60
Today|||52-Week Range
112.57
-16.16%
Year-to-Date

Today’s Trading

Previous close54.61
Today’s open54.11
Day’s range52.42 - 55.59
Volume722,622
Average volume (3 months)763,820
Market cap$3.7B
Dividend yield--
Data as of 3:59pm ET, 04/17/2014

Growth & Valuation

Earnings growth (last year)+31.28%
Earnings growth (this year)-36.69%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-29.31%
P/E ratioNM
Price/Sales83.91
Price/Book13.66

Competitors

 Today’s
change
Today’s
% change
ISISIsis Pharmaceuticals...-0.56-1.62%
PRXLPAREXEL Internationa...+0.19+0.38%
CRLCharles River Labora...-0.53-0.92%
ICLRICON PLC-0.26-0.59%
Data as of 4:02pm ET, 04/17/2014

Financials

Next reporting dateMay 5, 2014
EPS forecast (this quarter)-$0.54
Annual revenue (last year)$47.2M
Annual profit (last year)-$89.2M
Net profit margin-189.17%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maraganore
President &
Chief Operating Officer
Barry E. Greene
Corporate headquarters
Cambridge, Massachusetts

Forecasts